Biotech
Singapore’s ChemT Biotechnology raises $4M seed round to build AI intelligence layer for biomanufacturing
ChemT Biotechnology, an AI-driven biotechnology company based on Singapore, has closed a $4 million seed round led by Wavemaker Ventures and co-investment partner SEEDS, an arm of SG Growth Capital, with support from Wavemaker 360 Health, Draper University Ventures, and Temasek Life Sciences Accelerator.
Daiwa VC fund manager DCI Partners launches $135M fund to accelerate drug discovery
Tokyo-based DCI Partners, a venture fund manager of Daiwa Securities Group, has announced the launch of Daiwa Taiwan-Japan BioVenture Investment Limited Partnership II, a $135 million (JPY 14 billion) investment fund intended for drug discovery.
Singapore food startup gets funding for its ‘healthy’ ice cream
Will consumers scream for low-fat ice cream?
